Setting

Europe Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity

Published: 30 Jan 2022 | Report Code: 10248352 | Pages: 133

Europe autoimmune disease diagnostics market was valued at $1,312.0 million in 2021 and will grow by 8.3% annually over 2021-2031 owing to the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies. Highlighted with 38 tables and 71 figures, this 133-page report “Europe Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Assay Kits & Consumables • Analyzers & Instruments Based on Test Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Autoantibodies and Immunologic Tests o Antinuclear Antibody Tests o Anti-cyclic Citrullinated Peptide o Enzyme-Linked Immunosorbent Assay (ELISA) o Rheumatoid Factor o Thyroid Antibody Tests o Other Autoantibodies and Immunologic Tests • Inflammatory Marker Tests o C-Reactive Protein (CRP) o Erythrocyte Sedimentation Rate (ESR) o Other Inflammatory Marker Tests • Routine Laboratory Tests o Urinalysis o Complete Blood Count (CBC) Tests o Other Routine Laboratory Tests • Other Test Types Based on Disease Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Systemic Autoimmune Disease o Rheumatoid Arthritis o Systemic Lupus Erythematosus (SLE) o Psoriasis/Psoriatic Arthritis o Other Systemic Autoimmune Diseases • Localized Autoimmune Disease o Thyroiditis o Multiple Sclerosis o Inflammatory Bowel Disease o Type 1 Diabetes o Other Localized Autoimmune Diseases Based on Gender, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Female Patients • Male Patients Based on Age, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • < 44 • 44 - 64 • > 64 Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Clinics • Diagnostic Labs • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories Beckman Coulter, Inc. Biomerieux SA Bio-rad Laboratories Inc. F. Hoffmann-la Roche Ltd. Hemagen Diagnostics Inc. Myriad Genetics Inc. PerkinElmer Inc. (Euroimmun AG) Quest Diagnostics Inc. Siemens Healthineers Inc. Thermo Fisher Scientific Inc. Trinity Biotech PLC Werfen Company (Inova Diagnostics Inc.) (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Europe Market by Product	42
3.1 Market Overview by Product	42
3.2 Assay Kits & Consumables	44
3.3 Analyzers & Instruments	45
4 Segmentation of Europe Market by Test Type	46
4.1 Market Overview by Test Type	46
4.2 Autoantibodies and Immunologic Tests	48
4.2.1 Antinuclear Antibody Tests	50
4.2.2 Anti-cyclic Citrullinated Peptide	51
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA)	52
4.2.4 Rheumatoid Factor	53
4.2.5 Thyroid Antibody Tests	54
4.2.6 Other Autoantibodies and Immunologic Tests	55
4.3 Inflammatory Marker Tests	56
4.3.1 C-Reactive Protein (CRP)	58
4.3.2 Erythrocyte Sedimentation Rate (ESR)	59
4.3.3 Other Inflammatory Marker Tests	60
4.4 Routine Laboratory Tests	61
4.4.1 Urinalysis	63
4.4.2 Complete Blood Count (CBC) Tests	64
4.4.3 Other Routine Laboratory Tests	65
4.5 Other Test Types	66
5 Segmentation of Europe Market by Disease Type	67
5.1 Market Overview by Disease Type	67
5.2 Systemic Autoimmune Disease	69
5.2.1 Rheumatoid Arthritis	71
5.2.2 Systemic Lupus Erythematosus (SLE)	72
5.2.3 Psoriasis/Psoriatic Arthritis	73
5.2.4 Other Systemic Autoimmune Diseases	74
5.3 Localized Autoimmune Disease	75
5.3.1 Thyroiditis	77
5.3.2 Multiple Sclerosis	78
5.3.3 Inflammatory Bowel Disease	79
5.3.4 Type 1 Diabetes	80
5.3.5 Other Localized Autoimmune Diseases	81
6 Segmentation of Europe Market by Gender	82
6.1 Market Overview by Gender	82
6.2 Female Patients	84
6.3 Male Patients	85
7 Segmentation of Europe Market by Age	86
7.1 Market Overview by Age	86
7.2 < 44	88
7.3 44 - 64	89
7.4 > 64	90
8 Segmentation of Europe Market by End User	91
8.1 Market Overview by End User	91
8.2 Hospitals	93
8.3 Clinics	94
8.4 Diagnostic Labs	95
8.5 Other End Users	96
9 European Market 2021-2031 by Country	97
9.1 Overview of European Market	97
9.2 Germany	100
9.3 U.K.	102
9.4 France	105
9.5 Spain	107
9.6 Italy	109
9.7 Russia	111
9.8 Rest of European Market	113
10 Competitive Landscape	115
10.1 Overview of Key Vendors	115
10.2 New Product Launch, Partnership, Investment, and M&A	118
10.3 Company Profiles	119
Abbott Laboratories	119
Beckman Coulter, Inc.	121
Biomerieux SA	122
Bio-rad Laboratories Inc.	123
F. Hoffmann-la Roche Ltd.	124
Hemagen Diagnostics Inc.	125
Myriad Genetics Inc.	126
PerkinElmer Inc. (Euroimmun AG)	127
Quest Diagnostics Inc.	128
Siemens Healthineers Inc.	129
Thermo Fisher Scientific Inc.	130
Trinity Biotech PLC	131
Werfen Company (Inova Diagnostics Inc.)	132
RELATED REPORTS	133

List Of Tables:


Table 1.  Snapshot of Europe Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Health Spending by Region, $ bn, 2013-2020	29
Table 4.  Main Product Trends and Market Opportunities in Europe Autoimmune Disease Diagnostics Market	33
Table 5. Europe Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	42
Table 6. Europe Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, $ mn	46
Table 7. Europe Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, $ mn	49
Table 8. Europe Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, $ mn	57
Table 9. Europe Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, $ mn	62
Table 10. Europe Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	67
Table 11. Europe Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, $ mn	70
Table 12. Europe Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, $ mn	76
Table 13. Europe Autoimmune Disease Diagnostics Market by Gender, 2021-2031, $ mn	82
Table 14. Europe Autoimmune Disease Diagnostics Market by Age, 2021-2031, $ mn	86
Table 15. Europe Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	91
Table 16. Europe Autoimmune Disease Diagnostics Market by Country, 2021-2031, $ mn	99
Table 17. Germany Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	101
Table 18. Germany Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	101
Table 19. Germany Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	101
Table 20. U.K. Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	104
Table 21. U.K. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	104
Table 22. U.K. Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	104
Table 23. France Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	106
Table 24. France Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	106
Table 25. France Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	106
Table 26. Spain Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	108
Table 27. Spain Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	108
Table 28. Spain Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	108
Table 29. Italy Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	110
Table 30. Italy Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	110
Table 31. Italy Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	110
Table 32. Russia Autoimmune Disease Diagnostics Market by Product, 2021-2031, $ mn	112
Table 33. Russia Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, $ mn	112
Table 34. Russia Autoimmune Disease Diagnostics Market by End User, 2021-2031, $ mn	112
Table 35. Autoimmune Disease Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn	114
Table 36. Abbott Laboratories: Company Snapshot	119
Table 37. Abbott Laboratories: Business Segmentation	120
Table 38. Abbott Laboratories: Product Portfolio	120

List Of Figures:


Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. Europe Autoimmune Disease Diagnostics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of Europe Autoimmune Disease Diagnostics Market	25
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060	28
Figure 9. Primary Restraints and Impact Factors of Europe Autoimmune Disease Diagnostics Market	30
Figure 10. Investment Opportunity Analysis	34
Figure 11. Porter’s Fiver Forces Analysis of Europe Autoimmune Disease Diagnostics Market	37
Figure 12. Breakdown of Europe Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue	43
Figure 13. Europe Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)	43
Figure 14. Europe Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, $ mn	44
Figure 15. Europe Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, $ mn	45
Figure 16. Breakdown of Europe Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue	47
Figure 17. Europe Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%)	47
Figure 18. Europe Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, $ mn	48
Figure 19. Europe Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, $ mn	50
Figure 20. Europe Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, $ mn	51
Figure 21. Europe Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, $ mn	52
Figure 22. Europe Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, $ mn	53
Figure 23. Europe Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, $ mn	54
Figure 24. Europe Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, $ mn	55
Figure 25. Europe Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, $ mn	56
Figure 26. Europe Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, $ mn	58
Figure 27. Europe Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, $ mn	59
Figure 28. Europe Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, $ mn	60
Figure 29. Europe Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, $ mn	61
Figure 30. Europe Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, $ mn	63
Figure 31. Europe Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, $ mn	64
Figure 32. Europe Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, $ mn	65
Figure 33. Europe Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, $ mn	66
Figure 34. Breakdown of Europe Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue	68
Figure 35. Europe Addressable Market Cap in 2022-2031 by Disease Type, Value ($ mn) and Share (%)	68
Figure 36. Europe Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, $ mn	69
Figure 37. Europe Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, $ mn	71
Figure 38. Europe Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, $ mn	72
Figure 39. Europe Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, $ mn	73
Figure 40. Europe Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, $ mn	74
Figure 41. Europe Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, $ mn	75
Figure 42. Europe Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, $ mn	77
Figure 43. Europe Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, $ mn	78
Figure 44. Europe Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, $ mn	79
Figure 45. Europe Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, $ mn	80
Figure 46. Europe Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, $ mn	81
Figure 47. Breakdown of Europe Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue	83
Figure 48. Europe Addressable Market Cap in 2022-2031 by Gender, Value ($ mn) and Share (%)	83
Figure 49. Europe Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, $ mn	84
Figure 50. Europe Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, $ mn	85
Figure 51. Breakdown of Europe Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue	87
Figure 52. Europe Addressable Market Cap in 2022-2031 by Age, Value ($ mn) and Share (%)	87
Figure 53. Europe Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, $ mn	88
Figure 54. Europe Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, $ mn	89
Figure 55. Europe Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, $ mn	90
Figure 56. Breakdown of Europe Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue	91
Figure 57. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	92
Figure 58. Europe Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, $ mn	93
Figure 59. Europe Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, $ mn	94
Figure 60. Europe Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, $ mn	95
Figure 61. Europe Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	96
Figure 62. Breakdown of European Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue	98
Figure 63. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	99
Figure 64.  Autoimmune Disease Diagnostics Market in Germany, 2021-2031, $ mn	100
Figure 65.  Autoimmune Disease Diagnostics Market in U.K., 2021-2031, $ mn	102
Figure 66.  Autoimmune Disease Diagnostics Market in France, 2021-2031, $ mn	105
Figure 67.  Autoimmune Disease Diagnostics Market in Spain, 2021-2031, $ mn	107
Figure 68.  Autoimmune Disease Diagnostics Market in Italy, 2021-2031, $ mn	109
Figure 69.  Autoimmune Disease Diagnostics Market in Russia, 2021-2031, $ mn	111
Figure 70.  Autoimmune Disease Diagnostics Market in Rest of Europe, 2021-2031, $ mn	113
Figure 71. Growth Stage of Europe Autoimmune Disease Diagnostics Industry over the Forecast Period	115
Key Players:
 
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)